NHI NGUYEN: Open Payments
NPI 1922884303 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,338 in 58 payments from 15 companies in 2025. Trend: 2023 $301 · 2024 $2,196 · 2025 $1,338
Food & beverage: $1,338
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $356 |
| Novo Nordisk Inc | 5 | $202 |
| Arcutis Biotherapeutics, Inc. | 13 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $136 |
| ABBVIE INC. | 6 | $107 |
| Incyte Corporation | 4 | $102 |
| Amgen Inc. | 4 | $64 |
| UCB, Inc. | 2 | $55 |
| Organon LLC | 3 | $36 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
Products named: DUPIXENT, Zoryve, Ozempic, OPZELURA, LIBTAYO, Wegovy, Bimzelx, Otezla.
Industry payments across CA — which companies pay providers there.
